NASDAQ, JAZZ - Jazz Pharma Plc
We are a specialty pharmaceutical company focused on identifying, developing and
commercializing innovative products to meet unmet medical needs in neurology and
psychiatry. Our goal is to build a broad portfolio of products through a
combination of internal development and acquisition and in-licensing activities,
and to utilize our specialty sales force to promote our products in our target
markets. We apply novel formulations and drug delivery technologies to known
drug compounds, and to compounds with the same mechanism of action or similar
chemical structure as marketed products, to improve patient care by, among other
things, improving efficacy, reducing adverse side effects or increasing patient
compliance relative to existing therapies. ...
Read SEC Filing on NASDAQ.com »